The United Spinal Association, a nonprofit focused on improving the quality of life for people with spinal cord injuries and disorders [...]
The DECIDE trial compared daclizumab 150mg subcutaneous injection every 4 weeks with interferon (INF) beta-1a (Avonex) 30mcg once weekly [...]
Virtual reality diagnosis using a new mathematical model linked to balance can detect first signs of these disorders, it is [...]
An indirect comparison of results from randomized clinical trials in relapsing-remitting multiple sclerosis (RRMS) patients suggests [...]
In a large prospective study with validated measures of physical activity, researchers found no evidence that exercise reduced a woman’s [...]
A study published in the BMC Neurology journal emphasized that clear and regular communication between physicians and patients with [...]
Exposure to heavy metals and being female are associated with a higher incidence of multiple sclerosis (MS), according to a study conducted [...]
How the multiple sclerosis (MS) therapy Tecfidera (dimethyl fumarate) works on a molecular level has finally been uncovered, using a new [...]
A newly discovered potential biomarker of multiple sclerosis (MS) may help to distinguish between people who will go on to have less severe [...]
The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to [...]
